Document is current

Any future updates will be listed below

Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC

Crossref DOI link: https://doi.org/10.1038/s41571-025-01043-9

Published Online: 2025-06-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark